Thoracic Imaging

What Is the Best Initial Imaging for Suspected Diffuse Lung Disease?

·
What Is the Best Initial Imaging for Suspected Diffuse Lung Disease?

A 68-year-old man presents to your outpatient clinic with a six-month history of progressive shortness of breath on exertion and a persistent dry cough. His physical exam is notable for fine bibasilar crackles. There are no signs of acute infection or volume overload. You suspect a form of diffuse lung disease (DLD), but the differential is broad. Your immediate question is what imaging to order first to begin the workup without exposing the patient to unnecessary radiation or cost. For this initial evaluation, the American College of Radiology (ACR) rates a Radiography chest as Usually Appropriate, establishing it as the foundational first step in the diagnostic pathway.

## Who Fits This Clinical Scenario for Suspected Diffuse Lung Disease?
This guidance applies to patients presenting for the first time with signs and symptoms suggestive of a chronic, diffuse parenchymal lung process, often referred to as interstitial lung disease (ILD). The typical patient has an insidious onset of symptoms, such as gradually worsening dyspnea, a non-productive cough, or fatigue, often developing over months to years. Physical exam findings like bibasilar “velcro-like” crackles or digital clubbing further increase suspicion. The key element is that this is the initial workup; no prior diagnosis of DLD has been established.

This workflow is distinct from other clinical situations. It does not apply to:

  • Patients with a known diagnosis of DLD who are experiencing an acute worsening of their symptoms. This presentation suggests an acute exacerbation, infection, or other complication and routes to a different ACR variant: Confirmed diffuse lung disease. Suspected acute exacerbation or acute deterioration. Initial Imaging.
  • Patients with established DLD undergoing planned, routine monitoring. This follow-up imaging is guided by a separate set of recommendations: Confirmed diffuse lung disease without acute clinical deterioration. Routine follow-up imaging clinically indicated.
  • Patients with a clear alternative diagnosis. If the clinical picture strongly points to community-acquired pneumonia, acute heart failure, or pulmonary embolism, those specific diagnostic pathways should be followed instead.

## What Diagnoses Are You Working Up in This Scenario?
The term “diffuse lung disease” encompasses over 200 distinct disorders. The initial imaging serves to detect the presence of disease, narrow the broad differential, and guide subsequent, more definitive testing like high-resolution computed tomography (HRCT) or biopsy. Key considerations in the differential diagnosis include:

Idiopathic Pulmonary Fibrosis (IPF)
This is the most common and most aggressive of the idiopathic interstitial pneumonias, primarily affecting older adults. The prognosis is poor, making early and accurate diagnosis critical. Imaging seeks to identify a specific pattern known as usual interstitial pneumonia (UIP), characterized by reticulation and honeycombing with a basal and peripheral predominance.

Nonspecific Interstitial Pneumonia (NSIP)
NSIP can be idiopathic or, more commonly, associated with an underlying connective tissue disease (e.g., scleroderma, rheumatoid arthritis, myositis). It carries a significantly better prognosis than IPF. Its imaging appearance often involves ground-glass opacities and fine reticulation, typically with less honeycombing than IPF.

Hypersensitivity Pneumonitis (HP)
This condition results from an immunologic reaction to an inhaled organic antigen, such as mold or avian proteins. The chronic form of HP can mimic IPF. Imaging clues that may suggest HP include centrilobular nodules, air trapping (mosaic attenuation), and a mid-to-upper lung zone predominance.

Sarcoidosis
A multisystem inflammatory disease of unknown cause, sarcoidosis frequently affects the lungs. The classic radiographic finding is bilateral hilar lymphadenopathy, often accompanied by reticular or nodular opacities, typically with an upper-lobe predominance.

Pneumoconioses
These are occupational or environmental lung diseases caused by the inhalation of mineral dusts, such as asbestos (asbestosis) or silica (silicosis). A thorough exposure history is crucial, and imaging can reveal characteristic findings like pleural plaques in asbestosis or calcified hilar nodes (“egg-shell” calcification) in silicosis.

## Why Is a Chest Radiograph the Recommended First Step for Suspected DLD?
The ACR designates both chest radiography and non-contrast chest CT as ‘Usually Appropriate’ for the initial evaluation of suspected DLD. However, the chest radiograph serves as the ideal first-line study due to its accessibility, low cost, and minimal radiation dose, making it the logical starting point in nearly all cases.

Rationale for Chest Radiography
A standard two-view chest radiograph is an excellent screening tool. It can confirm the presence of diffuse parenchymal abnormalities, helping to solidify the clinical suspicion of DLD. While less sensitive than CT, it can often reveal characteristic patterns—such as the basal-predominant reticulation of IPF or the hilar adenopathy of sarcoidosis—that significantly narrow the differential diagnosis. Furthermore, it can identify unexpected alternative causes for the patient’s symptoms, such as cardiomegaly and pleural effusions suggesting heart failure, or a lung mass indicating malignancy. With an adult radiation dose of less than 0.1 mSv (☢), it is a very low-risk initial investigation.

Comparison to Other Modalities

  • CT chest without IV contrast: This study, specifically using high-resolution technique (HRCT), is the definitive imaging modality for characterizing DLD. While also rated ‘Usually Appropriate’, it is best reserved as the next step after an abnormal or inconclusive chest radiograph, or in cases where clinical suspicion remains high despite a normal radiograph. Starting with CT exposes the patient to a significantly higher radiation dose (☢☢☢ 1-10 mSv) and is less resource-efficient as a first-line screening tool.
  • CT chest with IV contrast: This is rated ‘May be appropriate’. Intravenous contrast does not improve the visualization of the lung interstitium and is therefore not necessary for the primary goal of diagnosing DLD. It adds potential risks (allergic reaction, contrast-induced nephropathy) and cost. Its use should be reserved for cases where there is a specific co-existing concern, such as suspected pulmonary embolism, aortic dissection, or malignancy requiring staging.
  • MRI chest: Rated ‘Usually not appropriate’. MRI lacks the spatial resolution required to visualize the fine architectural details of the lung parenchyma, such as septal thickening, micronodules, and early honeycombing. It is also highly susceptible to motion artifacts from breathing and cardiac pulsation, rendering it unsuitable for evaluating DLD.

## What Is the Downstream Workflow After the Initial Chest Radiograph?
The results of the initial chest radiograph will dictate the next steps in the diagnostic cascade. The goal is to move efficiently toward a confident diagnosis, which often requires a multidisciplinary discussion between pulmonology, radiology, and sometimes pathology.

  • If the radiograph is clearly abnormal and suggests DLD: The definitive next step is to order a CT chest without IV contrast, performed with high-resolution technique (HRCT). This provides the detailed anatomical information needed to classify the DLD pattern (e.g., UIP, NSIP, organizing pneumonia), which is a critical input for diagnosis and management.
  • If the radiograph is negative but clinical suspicion remains high: Do not stop the workup. Chest radiographs can be normal in up to 10-15% of patients with biopsy-proven DLD, especially in early disease. If the patient has compelling symptoms (e.g., progressive dyspnea) and signs (e.g., bibasilar crackles), proceeding directly to an HRCT is warranted.
  • If the radiograph is indeterminate or shows an unexpected finding: The next step depends on the finding. If signs of heart failure are present, the workup should pivot toward a cardiac evaluation. If a focal mass is seen, a contrast-enhanced CT may be needed for better characterization. If findings are subtle and non-specific, an HRCT remains the best test to clarify the nature of the parenchymal process.

Following HRCT, the patient’s case is often discussed in a multidisciplinary setting. Depending on the confidence of the imaging diagnosis, further steps may include pulmonary function testing, serologic testing for connective tissue diseases, and potentially bronchoscopy or surgical lung biopsy.

## Pitfalls to Avoid (and When to Get Help)
Navigating the initial workup for suspected DLD requires careful attention to clinical context and imaging selection. Common pitfalls include:

  • Stopping the workup after a normal chest radiograph: A normal radiograph does not rule out early or subtle DLD. High clinical suspicion should always prompt further investigation with HRCT.
  • Ordering a routine contrast-enhanced CT: Standard chest CT protocols are not optimized for interstitial detail. Always specify “high-resolution technique” or “HRCT” when DLD is the primary concern. IV contrast is not needed unless a specific vascular or neoplastic process is also suspected.
  • Attributing symptoms to age or deconditioning: The insidious onset of dyspnea in older adults can be easily dismissed. Maintaining a high index of suspicion for DLD is crucial for timely diagnosis.
  • Overlooking exposure history: A detailed occupational, environmental, and avocational history is essential, as it can be the key to diagnosing conditions like hypersensitivity pneumonitis or asbestosis.

If the clinical picture and imaging findings are complex or discordant, escalation to a pulmonologist with expertise in interstitial lung disease is the most appropriate next step.

## Related ACR Topics and Tools
This article covers one specific scenario within the broader topic of Diffuse Lung Disease. For a comprehensive overview and guidance on other clinical presentations, please consult the resources below.

Frequently Asked Questions

Why not start with a high-resolution CT (HRCT) for every patient with suspected DLD?

While HRCT is the gold standard for characterizing diffuse lung disease, a chest radiograph is the recommended first step. It is a low-cost, very low-radiation screening tool that can confirm the presence of disease, narrow the differential, or reveal an alternative diagnosis. This stepwise approach is more resource-efficient and avoids unnecessary radiation exposure for patients whose symptoms may be due to other, more common conditions.

What if the chest radiograph is normal but my clinical suspicion for DLD is very high?

A normal chest radiograph does not exclude diffuse lung disease, as it has limited sensitivity for early or subtle interstitial changes. If your clinical suspicion remains high based on symptoms (e.g., progressive dyspnea) and signs (e.g., bibasilar crackles), you should proceed directly to a high-resolution CT (HRCT) of the chest.

Is IV contrast ever needed when evaluating for diffuse lung disease?

For the primary purpose of evaluating the lung parenchyma for DLD, IV contrast is not necessary and does not improve visualization of interstitial patterns. The ACR rates CT with IV contrast as ‘May be appropriate’ because it should only be considered if there is a concurrent suspicion of another condition that requires contrast, such as pulmonary embolism, lung cancer, or aortic disease.

What is the difference between a ‘routine’ chest CT and an ‘HRCT’?

A high-resolution CT (HRCT) uses a specific imaging protocol to maximize spatial resolution of the lung parenchyma. This involves acquiring very thin slices (typically 1-1.5 mm) and using a sharp reconstruction algorithm. It often includes images taken at both full inspiration and expiration to assess for air trapping. A ‘routine’ chest CT uses thicker slices and is optimized for general evaluation of the mediastinum, pleura, and larger lung structures, not the fine detail of the interstitium.

Does this guidance apply to children with suspected diffuse lung disease?

Yes, the ACR guidance for this scenario includes pediatric considerations. A chest radiograph remains the ‘Usually Appropriate’ initial study. Radiation dose is a critical consideration in children, and the chest radiograph delivers a very low dose (☢ <0.03 mSv [ped]). Subsequent CT imaging in children must be performed using pediatric-specific, low-dose protocols.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026